Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Using IVC collapsibility and diameters to predict blood pressure drops during hemodialysis

Official title: The Predictive Value of the Inferior Vena Cava Collapsibility Index for Intradialytic Hypotension: A Prospective Multicenter Observational Stud

Run by First Affiliated Hospital of Wannan Medical College · NCT07033273 · Data updated 2026-11-12

This project tries to see whether measuring the inferior vena cava collapsibility index and diameters one hour into dialysis can predict blood pressure drops in adults on maintenance hemodialysis.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment188 (estimated)
SponsorFirst Affiliated Hospital of Wannan Medical College
Academic / other
Locations1 site (Wuhu, Anhui)
StatusRecruiting
StartedJanuary 27, 2025
Main results expectedJuly 31, 2025
Study endsJuly 31, 2025
Registry record updatedJune 24, 2025
Trial IDNCT07033273 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 years or older with end-stage renal disease receiving regular maintenance hemodialysis for at least three months who are hemodynamically stable and can undergo ultrasound are ideal candidates.

Probably not a fit

Patients with acute kidney injury, severe cardiac conditions (NYHA Class III–IV), those requiring vasopressor support, pregnant or breastfeeding women, or those unable to undergo ultrasound are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter prospective observational study that records inferior vena cava (IVC) measurements once, at one hour after dialysis start, to see how well IVCCI, IVCmax, and IVCmin predict intradialytic hypotension. Ultrasound measurements will be collected at participating hospitals in Wuhu and linked to blood pressure readings and dialysis session data. Eligible participants are adults with end-stage renal disease on maintenance hemodialysis for at least three months, while patients with acute kidney injury, severe cardiac disease, hemodynamic instability, or barriers to ultrasound are excluded. The study uses noninvasive bedside ultrasonography and correlational analysis to determine whether a single-timepoint IVC metric can identify patients at higher risk of hypotension during dialysis.

Why it matters

Potential benefit: If successful, this approach could provide a simple, noninvasive bedside tool to identify patients at higher risk of intradialytic hypotension so teams can adjust fluid removal or apply preventive measures.

How similar studies have gone: Prior small observational studies have suggested a relationship between IVC collapsibility/diameters and intravascular volume or hypotension risk, but results have been mixed and larger prospective validation is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older.
* Diagnosed with end-stage renal disease (ESRD).
* Undergoing regular hemodialysis for at least three months.

Exclusion Criteria:

* Pregnant or breastfeeding women.
* Hemodynamically unstable patients or those requiring vasopressor support.
* Patients with severe cardiac conditions, including congestive heart failure -classified as NYHA Class III-IV or severe valvular disease.
* Patients with known allergies to dialysis filters.
* Dialysis sessions terminated for reasons unrelated to hypotension (e.g., technical issues, patient request).
* Patients who withdraw informed consent during the study.
* Use of antihypertensive medications during dialysis sessions.
* Inability to undergo ultrasound assessment due to factors such as severe obesity or wounds obstructing access.

Where it's running

  • The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
    Wuhu, Anhui, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.